Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-04-10
2007-04-10
Whiteman, Brian (Department: 1635)
Chemistry: molecular biology and microbiology
Vector, per se
Reexamination Certificate
active
10812912
ABSTRACT:
Liquid or frozen compositions containing adenoviral-particles, comprising a buffer solution capable of maintaining the pH of the medium at slightly alkaline values, supplemented with glycerol and without addition of divalent metal cations or of alkali metal cations.
REFERENCES:
patent: 5871464 (1999-02-01), Tryggvason et al.
patent: 6451256 (2002-09-01), Sene
patent: 6734008 (2004-05-01), Blanche et al.
patent: 2002/0031527 (2002-03-01), Wu et al.
patent: WO 98/02522 (1998-01-01), None
U.S. Appl. No. 60/133,116, filed May 7, 1999, Wu et al.
U.S. Appl. No. 60/108,606, filed Nov. 16, 1999, Wu et al.
Amin, R., et al., “Replication-Deficient Adenovirus Induces Expression of Interleukin-8 by Airway Epithelial CellsIn Vitro,” Human Gene Therapy, 6:145-153 (1995).
Bajocchi, G., et al., “DirectIn VivoGene Transfer to Ependymal Cells in the Central Nervous System Using Recombinant Adenovirus Vectors,” Nature Genetics, 3:229-234, (1993).
Colak, A., et al., “Adenovirus-Mediated Gene Therapy in an Experimental Model of Breast Cancer Metastatic to the Brain,” Human Gene Therapy, 6:1317-1322 (1995).
Crystal, R.G., et al., “A Phase 1 Study, in Cystic Fibrosis Patients, of the Safety, Toxicity, and Biological Efficacy of a Single Administration of a Replication Deficient, Recombinant Adenovirus Carrying the cDNA of the Normal Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Lung,” Human Gene Therapy, 6:643-666 (1995).
Fang, B., et al., “Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression,” Human Gene Therapy, 6:1039-1044 (1995).
Kagami, H., et al., “Evidence for the Systemic Delivery of a Transgene Product from Salivary Glands,” Human Gene Therapy, 7:2177-2184 (1996).
Korst, R.J., et al., “In VitroandIn VivoTransfer and Expression of Human Surfactant SP-A- and SP-B-Associated Protein cDNAs Mediated by Replication-Deficient, Recombinant Adenoviral Vectors,” Human Gene Therapy, 6:277-287 (1995).
Lieber, A., et al., “Adenovirus-Mediated Transfer of the Amphotropic Retrovirus Receptor cDNA Increases Retroviral Transduction in Cultured Cells,” Human Gene Therapy, 6:5-11 (1995).
Mittereder, N., et al., “Evaluation of the Concentration and Bioactivity of Adenovirus Vectors for Gene Therapy,” Journal of Virology, 70:7498-7509 (1996).
Rosenfeld, M.A., et al., “In VivoTransfer of the Human Cystic Fibrosis Transmembrane Conductance Regular Gene to the Airway Epithelium,” Cell, 68:143-155 (1992).
Sene, C., et al., “Aerosol-Mediated Delivery of Recombinant Adenovirus to the Airways of Nonhuman Primates,” Human Gene Therapy, 6:1587-1593 (1995).
Von Seggern, D.J., et al., “A Helper-Independent Adenovirus Vector with E1, E2, and Fiber Deleted: Structure and Infectivity of Fiberless Particles,” Journal of Virology, 73:1601-1608 (1999).
Vrancken Peeters, M-J, et al., “Adenovirus-Mediated Hepatic Gene Transfer in Mice: Comparison of Intravascular and Biliary Administration,” Human Gene Therapy, 7:1693-1699 (1996).
Blanche Francis
Shih Shian-Jiun
Centelion
Finnegan Henderson Farabow Garrett & Dunner LLP
Whiteman Brian
LandOfFree
Composition intended for the preservation of infectious... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition intended for the preservation of infectious..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition intended for the preservation of infectious... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3799459